Kymera Therapeutics Inc. (KYMR)
NASDAQ: KYMR
· Real-Time Price · USD
54.65
-1.95 (-3.45%)
At close: Oct 01, 2025, 1:50 PM
-3.45% (1D)
| Bid | 54.61 |
| Market Cap | 3.91B |
| Revenue (ttm) | 44.71M |
| Net Income (ttm) | -275.43M |
| EPS (ttm) | -3.63 |
| PE Ratio (ttm) | -15.06 |
| Forward PE | -14.66 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 54.73 |
| Volume | 680,311 |
| Avg. Volume (20D) | 720,922 |
| Open | 56.30 |
| Previous Close | 56.60 |
| Day's Range | 54.55 - 56.89 |
| 52-Week Range | 19.45 - 58.93 |
| Beta | 2.18 |
| Ex-Dividend Date | n/a |
About KYMR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KYMR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for KYMR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsKymera Therapeutics Inc. is scheduled to release its earnings on
Oct 30, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-7.24%
Kymera Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
3 months ago
-1.42%
Kymera Therapeutics shares are trading lower after the company announced a $250 million public offering.
